731 to 740 of 20,926 Results
Texto plano - 5,3 KB -
MD5: 560b3dd5873f122ca4fdf6add139eb73
|
May 28, 2026 - Universidad Rey Juan Carlos
Onrubia-Márquez, Mónica; Martínez García, Miguel Ángel; Navas, Francisco; Martinez-Erro, Samuel; Martin Rengel, Antonio; Morales, Victoria; Justine Delaval; Merchán Sánchez, Lara; Sanchez-Robles, Eva María; Paniagua, Nancy; RODRIGUEZ-RIVERA, CARMEN; Sanz Martin, Raul; Goicoechea, Carlos; Garcia-Muñoz, Rafael A., 2026, "MSN Templated with L-Dopa Amide Derivatives Outperforms the Efficiency of Free-L-Dopa in Reducing Parkinson’s Behavioral Dysfunction in Mice", https://doi.org/10.21950/ZJTMTE, e-cienciaDatos, V1
Introduction: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor dysfunction due to the loss of dopaminergic neurons, with an increasing global prevalence estimated to impact 20 million individuals by 2050. The current standard treatment, L-dopa, loses efficacy over time and often induces dyskinesia, highlig... |
Hoja de cálculo MS Excel - 193,4 KB -
MD5: eacab2feada24175812383f97eddec30
|
Texto plano - 22,7 KB -
MD5: 80bf46a741ec9d4b675232443da5db4c
|
May 28, 2026 - Universidad Rey Juan Carlos
Griso Acevedo, Ana Belén; Navas, Francisco; natalia calvo; Morales, Victoria; CASTELO FERNÁNDEZ, Beatriz; GONZÁLEZ MARTÍN-MORO, JAVIER; Moran, Maria Jose; Sanz Martin, Raul; Cebrián Carretero, José Luis; Garcia-Muñoz, Rafael A.; Sastre, Ana, 2026, "Overcoming Cisplatin Resistance in 3D Oral Squamous Cell Carcinoma Models via Nanoparticle-Mediated Pt(IV) Drug Delivery", https://doi.org/10.21950/AMREIU, e-cienciaDatos, V1
Advanced oral squamous cell carcinoma (OSCC) patients with cisplatin-refractory tumors face a poor prognosis and limited therapeutic options. Cisplatin-based systemic chemotherapy has long been the gold standard despite producing unmanageable adverse side effects and toxicity. Compared to Pt(II)-based analogs, octahedral Pt(IV)-based compounds have... |
May 28, 2026 -
Overcoming Cisplatin Resistance in 3D Oral Squamous Cell Carcinoma Models via Nanoparticle-Mediated Pt(IV) Drug Delivery
Texto plano - 20,9 KB -
MD5: 0a1b371c16110422938f205ed72db36f
|
May 28, 2026 -
Overcoming Cisplatin Resistance in 3D Oral Squamous Cell Carcinoma Models via Nanoparticle-Mediated Pt(IV) Drug Delivery
Texto plano - 20,9 KB -
MD5: 574e4fc2bcc5da795a2da77300e96362
|
May 27, 2026 - Universidad Rey Juan Carlos
Navarro, Marta; Garcés Osado, Andrés; Moya, Carmen; Lara Sánchez, Agustín; SÁNCHEZ-BARBA MERLO, LUIS FERNANDO, 2026, "Microstructural Control of L-Lactide/ε-Caprolactone Copolymers Using Amidinate-Based Aluminum Catalysts", https://doi.org/10.21950/0F9EXD, e-cienciaDatos, V2
The development of copolymers derived from L-lactide (L-LA) and ε-caprolactone (CL) represents a sustainable strategy in the design of next-generation biodegradable materials, alternative to conventional non-degradable industrial polymers. In this work, novel dialkyl and alkyl/alkoxide aluminum complexes supported by scorpionate-derived ligands hav... |
May 27, 2026 -
Microstructural Control of L-Lactide/ε-Caprolactone Copolymers Using Amidinate-Based Aluminum Catalysts
Tabular Data - 1,2 KB
|
May 27, 2026 -
Microstructural Control of L-Lactide/ε-Caprolactone Copolymers Using Amidinate-Based Aluminum Catalysts
Texto plano - 7,0 KB -
MD5: a0352c14505f7c3a1f770f314eb7dbd1
|
